Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, September 12, 2011 ) Belize City, Belize -- EAPH's leading edge technology, Viorra, is an over-the-counter topical gel that is safe and effective. The key to EAPH success is that the product is near distribution.
EAPH's last corporate update at the beginning of August hinted of many more updates to follow. Xtremepicks.com is anticipating a series of press releases on their patent process, distribution, and clinical trials any day now.
Xtremepicks.com has put EAPH on alert Friday in anticipation that investors will be getting some significant updates fairly soon - xtremepicks.com is looking at ground breaking news that can give members in excess of 1,000%+ potential gains with this bottom bounce play.
EAPH is ViagraTM on Steroids!
EAPH closed at $0.065 up 132.14% on the single highest trading day in company history - stay tuned for a crazy week ahead!
EAPH - Easton Pharmaceuticals and the $5.5 Billion Market Stay tune next week as we anticipate significant updates from the company which can add a huge boost to this play.
A publicly-traded company listed on the NASDAQ and the OTCPK, Easton Pharmaceuticals is targeting the estimated $2 billion market for FSAD. Easton, EAPH's CEO is also developing a pipeline of transdermal products using the VD™ technology in Viorra for a variety of applications including topical treatments for women and men seeking to diminish scars, adhesions, cellulite, varicose veins, and stretch marks. The Company believes these additional applications target an estimated $3.5 billion market for treatments to diminish the appearance of damaged and aging skin which Easton's subsequent products will address.
ABOUT EAPH - EASTON PHARMACEUTICALS
Easton Pharmaceuticals is a specialty pharmaceutical company that designs, develops and markets a range of premium, topically delivered therapeutic health care products. The company's proprietary gel formulation is an innovative and unique transdermal delivery system.
The system is the technology that allows for the rapid development of non-invasive, naturally derived topical solutions that have the ability to revitalize and stimulate the healing of a variety of skin and tissue conditions. The transdermal delivery system allows for the targeted delivery of active ingredients, vitamins and herbs through the skin to the underlying tissue.
The company has utilized its transdermal delivery system to develop a safe and effective female sexual enhancement product. The companyÂ’s goal is to develop a portfolio of topical pharmaceutical and cosmeceutical products targeting various skin and tissue conditions including: scars and stretch marks, cellulite and varicose veins.
Xtremepicks.com your trading connection and remember to always do your own research, use stop loss orders to protect yourself, and book your profits when in a position to do so.
Xtremepicks.com profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do your own due diligence. Xtremepicks received $20K for a 2 week profile of EAPH from Direct Global Media and at times may buy EAPH in the open market. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. Click here to view the full disclaimer
Directglobalmedia.com
Max Gordon
6479227508
contact@directglobalmedia.com
Source: EmailWire.com
|
|
|
|